Persistent genital arousal in women - A new syndrome entity

International Journal of STD and AIDS

Volumn 17, Issue 4, 2006, Pages 215-216

  Goldmeier, David ^a   Leiblum, Sandra R ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Persistent arousal; Women

Indexed keywords

ANTIDEPRESSANT AGENT; ATRIAL NATRIURETIC FACTOR; PAROXETINE; PHYTOESTROGEN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; VASOPRESSIN;

ARTERIOVENOUS FISTULA; CLINICAL FEATURE; DEPRESSION; DISTRESS SYNDROME; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE GENITAL SYSTEM; GENITAL EDEMA; HUMAN; NERVE COMPRESSION; PRIORITY JOURNAL; REVIEW; SEXUAL AROUSAL DISORDER; SYNDROME;

DEPRESSIVE DISORDER; FEMALE; HUMANS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SYNDROME; WOMEN'S HEALTH;

EID: 33645541124     PISSN: 09564624     EISSN: 09564624     Source Type: Journal    
DOI: 10.1258/095646206776253480     Document Type: Review

References (14)

1. Laumann EO, Paik A, Rosen R. Sexual dysfunction in the United States. Prevalence and predictors. JAMA 1999;281:537-44
2. Mercer CH, Fenton KA, Johnson AM, et al. Sexual function problems and health seeking behaviour in Britain: national probability sample survey. BMJ 2003;327:426-7
3. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunctions reconsidered: advocating expansion and revision. J Psychosom Obstet Gynecol 2003;24:221-9
4. Leiblum SR, Nathan SG. Persistent sexual arousal syndrome: a newly discovered pattern of female sexuality. J Sex Marital Ther 2001;27:365-80
5. Leiblum S, Brown C, Wan J, Rawlinson L. Persistent sexual arousal syndrome: a descriptive study. J Sex Med 2005;2:331-337
6. Crowley T, Goldmeier D, Richardson D. Persistent sexual arousal in a woman with an atrial septal defect - is increased atrial natriuretic pepetide the cause. In: Poster 54 ISSWSH Conference, Las Vegas, October 2005
7. Amsterdam A, Abu-Rustum N, Carter J, Krychman M. Persistent sexual arousal syndrome associated with increased soy intake. J Sex Med 2005;2:338-40
8. Freed L. Persistent sexual arousal syndrome. J Sex Med 2005;2:743
9. Bogetto F, Bellino S, Revello RB, Patria L. Dyscontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors. CNS Drugs 2002;16:273-83
10. Green B. Persistent adverse neurological effects following SSRI discontinuation (PANES) Psychiatry online [www. itascapsych.com/pharm_arch7. html]
11. Curry FR. Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport and plasma volume. J Clin Invest 2005;115:1458-61
12. Kellner CH, Patrides G, Fredrickse M, Yero S, Goldstein I. Relief of expressed suicidal intent by electroconvulsive therapy (ECT) in a woman with persistent sexual arousal syndrome (PSAS). ISSWSH Conference, Las Vegas Podium 15, October 2005
13. Ishihara K, Sasa M. Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression. Japan J Pharmacol 1999;80:185-9
14. Strome EM, Clark CM, Zis AP, Doudet DJ. Electroconvulsive hock decreases binding to 5 HT2 receptors in non human primates: an in vivo positron emission tomography study with [18F] setoperone. Biol Psychiatr 2005;57:1004-1010